How insulin boosts immune system

Image
ANI Washington D.C. [USA]
Last Updated : Aug 31 2018 | 7:15 AM IST

Insulin, a peptide hormone produced by beta cells of the pancreatic islets, boosts immune health, according to a new study.

Toronto General Hospital Research Institute (TGHRI) scientists have identified a specific insulin signaling pathway that, when activated, revs up the response of T cells in the immune system to divide rapidly and secrete cytokines, chemical messenger proteins that activate the rest of the immune system.

A fast and effective immune response protects us against disease and life-threatening infections by destroying infected cells or microbes, while a wrong or inefficient one can cause immune system disorders or diseases to develop.

"We have identified one of metabolism's most popular hormones, specifically the insulin signalling pathway, as a novel 'co-stimulatory' driver of immune system function," said Assistant Professor, Dr Dan Winer.

Although much work has been done in past years on the role of insulin in organs such as the liver, muscle and in fat to understand the regulation of glucose or blood sugar and how the body metabolizes or turns it into energy, little is known about how insulin impacts the immune system.

The goal of this research was to study how insulin regulates T cell function and what causes T cells to stop responding to insulin, Dr Tsai says, adding that T cells were chosen because they play a pivotal role in self-defense against infections.

Using genetically engineered mice, the research team designed mice with T cells that did not have an insulin receptor on them, mimicking insulin resistance. They then observed what happened to the T cells in the mice under different stressors, such as the H1N1 flu virus.

Without the added boost or kickstart provided by the insulin receptor to help "re-energize" the T cells to mount an effective immune response, the T cells failed to destroy viruses such as H1N1 influenza.

First author Dr Sue Tsai said, "In the future, we could harness this insulin signalling pathway to either boost the immune response to create vaccines, for example, or dampen it to heal inflammatory illnesses such as arthritis, ulcerative colitis and Crohn's disease."

The full findings are present in the journal- Cell Metabolism.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 31 2018 | 7:15 AM IST

Next Story